language_icon
EN
HI

Sun Pharma Advanced Research Company Share price

SPARC

143.54

0.00 (0.00%)
NSE
BSE
Last updated on 22 Apr, 2026 | 15:55 IST
Today's High

146.00

Today's Low

143.00

52 Week Low

108.00

52 Week High

204.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sun Pharma Advanced Research Company Chart

Sun Pharma Advanced Research Company Share Key Metrics

Volume
4.39 L
Market Cap
4657.87 CR
LTQ@LTP
10@143.54
ATP
144.05
Var Margin
24.74 %
Circuit Range
114.84-172.24
Delivery %
28.43 %
Value
6.32 CR
ASM/GSM
No
Market Lot
1

Summary

Sun Pharma Advanced Research Company share price stands at ₹143.54 at 22 Apr, 2026 | 15:55. The stock Sun Pharma Advanced Research Company intraday movement has stayed between ₹143.00 and ₹146.00, while on a 52-week basis it has fluctuated from ₹108.00 to ₹204.40.
In terms of trading activity, Sun Pharma Advanced Research Company has recorded a volume of 438757 shares. The Sun Pharma Advanced Research Company has a market cap of ₹324499558. The stock’s Average Traded Price (ATP) stands at ₹14405, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10, 14354.
The Sun Pharma Advanced Research Company operates within a circuit range of ₹114.84-172.24 – ₹114.84-172.24, with a Value of ₹6.32 CR. The Delivery Percentage for the day is 28.43%. Additionally, Sun Pharma Advanced Research Company currently falls under the No framework, and trades with a market lot size of 1.

Sun Pharma Advanced Research Company Fundamentals

View More
P/E Ratio

0

P/B Ratio

-11.04

Div. Yield

0

Sector P/E

24.02

Sector P/B

2.91

Sec. Div. Yield

1.13

Sun Pharma Advanced Research Company Resistance and Support

Pivot 144.18

Resistance

First Resistance

145.36

Second Resistance

147.18

Third Resistance

148.36

Support

First Support

142.36

Second Support

141.18

Third Support

139.36

Sun Pharma Advanced Research Company Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

65.67%

Mutual Fund

0.85%

Insurance

0%

Foreign Institutional Investors

2.04%

Domestic Institutional Investors

0.02%

Retail

31.42%

Others

0%

Total Promoters
MAR '26
65.67%

Sun Pharma Advanced Research Company Corporate Actions

DateAgenda
2026-02-09Quarterly Results
2026-01-14To consider issue of Warrants & ESOP
2025-11-10Quarterly Results
2025-08-04Quarterly Results
2025-05-19Audited Results
2025-02-10Quarterly Results

Sun Pharma Advanced Research Company News

Sun Pharma Advanced Research Company Limited

Dilip S. Shanghvi, promoter of Sun Pharma Advanced Research Company Limited, declared no new encumbrance on the company's shares as of March 31, 2026. This confirms that all existing encumbrances were already disclosed during the financial year, ensuring compliance with SEBI regulations.
Apr 22 2026 17:04:00

Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Change in Management

Dr. Shravanti Bhowmik, Head of Operations Management at SPARC and Senior Management Team member, resigned effective March 31, 2026. This transition is for a new role within the same group company.
Apr 03 2026 12:04:00

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company announced the resignation of Dr. Shravanti Bhowmik, Head of Operations Management and a member of the Senior Management Team, effective March 31, 2026. She is transitioning to a new opportunity within the group company, as per her resignation letter.
Apr 03 2026 12:04:00

Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Change in Management

SPARC announced Dr. Shravanti Bhowmik's resignation as VP, Operations Management, effective March 31, 2026. Simultaneously, Narendra Lakkad has been appointed as Head - Corporate Development and Operations Management, effective April 01, 2026, bringing prior experience from Sun Pharma group and Shantilal Shanghvi Foundation.
Mar 27 2026 18:03:00

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research accepted the resignation of Dr. Shravanti Bhowmik, VP, Operations Management, effective March 31, 2026. Concurrently, Mr. Narendra Lakkad was appointed as Head - Corporate Development and Operations Management, effective April 01, 2026, bringing his extensive experience within the Sun Pharma group to this role.
Mar 27 2026 18:03:00
Read More

About Sun Pharma Advanced Research Company

NSE : 14788  
BSE : 532872  
ISIN : INE232I01014  

Sun Pharma Advanced Research Company Management

NamePosition
Kajal DamaniaCompany Secretary & Compliance Officer
Dilip S ShanghviChairman
View More

Sun Pharma Advanced Research Company FAQs

The Buying Price of Sun Pharma Advanced Research Company share is 143.54 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sun Pharma Advanced Research Company stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sun Pharma Advanced Research Company, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sun Pharma Advanced Research Company shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sun Pharma Advanced Research Company shares is -11.04. Useful to assess the stock's value relative to its book value.

To assess Sun Pharma Advanced Research Company’s valuation compare Sector P/E, P/B which are 24.02 & 2.91 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sun Pharma Advanced Research Company is 4657.87 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sun Pharma Advanced Research Company share price is 204.40 & 108.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sun Pharma Advanced Research Company belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost